Burning mouth syndrome: Clinical description, pathophysiological approach, and a new therapeutic option

作者：Carcamo Fonfria A; Gomez Vicente L; Pedraza M I; Cuadrado Perez M L; Guerrero Peral A L; Porta Etessam J

来源：Neurologia, 2017, 32(4): 219-223.

DOI：10.1016/j.nrl.2015.10.008

• Burning mouth
• Glossopyrosis
• Disabling
• Treatment
• Dopamine agonists

Introduction: Burning mouth syndrome is defined as scorching sensation in the mouth in the absence of any local lesions or systemic disease that would explain that complaint. The condition responds poorly to commonly used treatments and it may become very disabling.
Methods: We prospectively analysed the clinical and demographic characteristics and response to treatment in 6 cases of burning mouth syndrome, diagnosed at 2 tertiary hospital headache units.
Results: Six "female patients between the ages of 34 and 82 years reported symptoms compatible with burning mouth syndrome. In 5 of them, burning worsened at the end of the day; 4 reported symptom relief with tongue movements. Neurological examinations and laboratory findings were normal in all patients and their dental examinations revealed no buccal lesions. Each patient had previously received conventional treatments without amelioration. Pramipexol was initiated in doses between 0.36 mg and 1.05 mg per day, resulting in clear improvement of symptoms in all cases, a situation which continues after a 4-year follow up period.
Conclusions: Burning mouth syndrome is a condition of unknown aetiology that shares certain clinical patterns and treatment responses with restless leg syndrome. Dopamine agonists should be regarded as first tine treatment for this entity.

• 出版日期2017-5